AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 277 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,618,000 | +39.3% | 156,676 | -14.8% | 0.45% | +20.7% |
| Q3 2020 | $2,597,000 | -28.7% | 183,942 | -23.9% | 0.37% | -37.7% |
| Q2 2020 | $3,644,000 | +153.8% | 241,634 | +103.4% | 0.60% | +253.3% |
| Q3 2018 | $1,436,000 | -23.9% | 118,789 | -1.7% | 0.17% | -28.4% |
| Q2 2018 | $1,888,000 | +3.9% | 120,901 | 0.0% | 0.24% | -1.3% |
| Q1 2018 | $1,818,000 | +0.8% | 120,901 | -3.6% | 0.24% | +0.4% |
| Q4 2017 | $1,804,000 | -25.6% | 125,381 | -22.1% | 0.24% | -27.9% |
| Q3 2017 | $2,426,000 | +72.8% | 160,889 | +15.4% | 0.33% | +64.2% |
| Q2 2017 | $1,404,000 | – | 139,415 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |